CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 75 enrolled
Drug / intervention
Bupivacaine Hydrochloride 0.5% Injection Solution_#4 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03225313
NCT03225313N/ACompleted
CompareCT.gov

Ultra Sound Guided Rectus Sheath Block or Field Block for Midline Hernia Repair: A Comparative Study

Theodor Bilharz Research Institute·interventional·Posted Jul 21, 2017·Updated Mar 9, 2021

In Brief

A clinical study evaluating Bupivacaine Hydrochloride 0.5% Injection Solution_#4 and Normal Saline Flush, 0.9% Injectable Solution_#5 for Ultrasound Guided Rectus Sheath Block and Pain, Postoperative. Completed, enrolled 75 participants across 1 site.

Detailed Summary

Randomized double blinded controlled clinical trial will be done with a total number of 75 patients will be divided into 3 groups. To compare between Ultra-sound guided rectus sheath block VS Field block infiltration in providing a good analgesia for patients undergoing midline hernia repair to detect which one is superior.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUltrasound Guided Rectus Sheath Block, Pain, Postoperative
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 21, 2017
Enrollment StartAug 10, 2017
Primary CompletionDec 30, 2017
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 8.9 years ago

Interventions

Bupivacaine Hydrochloride 0.5% Injection Solution_#4drug

ultra sound guided injection into the rectus sheath

Normal Saline Flush, 0.9% Injectable Solution_#5drug

injected into rectus sheath using ultrasound \& locally surrounding the hernia

Bupivacaine Hydrochloride 0.5% Injection Solution_#4drug

locally surrounding the hernia